M&T Bank Corp Cuts Position in DaVita Inc. (NYSE:DVA)

M&T Bank Corp lessened its stake in DaVita Inc. (NYSE:DVA) by 13.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,163 shares of the company’s stock after selling 498 shares during the quarter. M&T Bank Corp’s holdings in DaVita were worth $483,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in DVA. Raymond James Financial Inc. purchased a new position in shares of DaVita in the 4th quarter valued at about $3,864,000. Sequoia Financial Advisors LLC boosted its stake in shares of DaVita by 6.2% during the 4th quarter. Sequoia Financial Advisors LLC now owns 1,897 shares of the company’s stock worth $284,000 after purchasing an additional 110 shares during the last quarter. Cibc World Markets Corp boosted its stake in shares of DaVita by 8.6% during the 4th quarter. Cibc World Markets Corp now owns 7,194 shares of the company’s stock worth $1,076,000 after purchasing an additional 571 shares during the last quarter. Advisors Asset Management Inc. boosted its stake in shares of DaVita by 24.6% during the 4th quarter. Advisors Asset Management Inc. now owns 22,686 shares of the company’s stock worth $3,393,000 after purchasing an additional 4,485 shares during the last quarter. Finally, Intech Investment Management LLC boosted its stake in shares of DaVita by 1.2% during the 4th quarter. Intech Investment Management LLC now owns 27,265 shares of the company’s stock worth $4,077,000 after purchasing an additional 328 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of NYSE:DVA opened at $140.23 on Thursday. The firm has a market capitalization of $10.59 billion, a PE ratio of 13.90, a P/E/G ratio of 0.97 and a beta of 1.11. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The business has a 50-day moving average of $140.16 and a two-hundred day moving average of $148.67. DaVita Inc. has a 12 month low of $131.76 and a 12 month high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.25. The company had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.26 earnings per share. As a group, research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Wall Street Zen upgraded DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Truist Financial cut their price target on DaVita from $170.00 to $164.00 and set a “hold” rating for the company in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $164.50.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.